v3.25.2
EQUITY
 6 Months Ended
Jun. 30, 2025
Stockholders' Equity Note [Abstract]  
EQUITY EQUITY
The following tables present the changes in consolidated equity (dollars in millions, share amounts in thousands):
Common StockAdditional
Paid-In
Capital		Accumulated
Other
Comprehensive
Loss		Retained EarningsTreasury
Stock		Noncontrolling
Interests		Total Equity
Shares
Outstanding		Issued Par
Amount
Balances at December 31, 202495,109 $8 $4,873 $(180)$3,008 $(3,538)$1,649 $5,820 
Net income— — — — 406 — 95 501 
Distributions paid to noncontrolling interests— — — — — — (89)(89)
Other comprehensive income— — — 2 — — — 2 
Net purchases (sales) of businesses and noncontrolling interests— — (35)— — — 41 6 
Repurchases of common stock(2,629)— — — — (351)— (351)
Stock-based compensation expense, tax benefit and issuance of common stock405 — (12)— — — — (12)
Balances at March 31, 202592,885 8 4,826 (178)3,414 (3,889)1,696 5,877 
Net income— — — — 288 — 105 393 
Distributions paid to noncontrolling interests— — — — — — (83)(83)
Other comprehensive income— — — 1 — — — 1 
Net purchases of businesses and noncontrolling interests— — 10 — — — 9 19 
Repurchases of common stock(4,601)— — — — (753)— (753)
Stock-based compensation expense, tax benefit and issuance of common stock60 — 22 — — — — 22 
Balances at June 30, 202588,344 $8 $4,858 $(177)$3,702 $(4,642)$1,727 $5,476 
Common StockAdditional
Paid-In
Capital		Accumulated
Other
Comprehensive
Loss		Retained Earnings
(Accumulated
Deficit)		Treasury
Stock		Noncontrolling
Interests		Total Equity
Shares
Outstanding		Issued Par
Amount
Balances at December 31, 202399,950 $8 $4,834 $(181)$(192)$(2,861)$1,509 $3,117 
Net income— — — — 2,151 — 82 2,233 
Distributions paid to noncontrolling interests— — — — — — (78)(78)
Other comprehensive income— — — 2 — — — 2 
Net sales of businesses and noncontrolling interests— — (5)— — — (23)(28)
Repurchases of common stock(2,811)— — — — (280)— (280)
Stock-based compensation expense, tax benefit and issuance of common stock534 — (23)— — — — (23)
Balances at March 31, 202497,673 8 4,806 (179)1,959 (3,141)1,490 4,943 
Net income— — — — 259 — 97 356 
Distributions paid to noncontrolling interests— — — — — — (70)(70)
Other comprehensive income— — — 2 — — — 2 
Net purchases of businesses and noncontrolling interests— — 12 — — — 64 76 
Repurchases of common stock(1,990)— — — — (273)— (273)
Stock-based compensation expense and issuance of common stock136 — 22 — — — — 22 
Balances at June 30, 202495,819 $8 $4,840 $(177)$2,218 $(3,414)$1,581 $5,056 
Nonredeemable Noncontrolling Interests
The table below presents our nonredeemable noncontrolling interests balances by segment:
 June 30, 2025December 31, 2024
Hospital Operations$215 $205 
Ambulatory Care1,512 1,444 
Total nonredeemable noncontrolling interests$1,727 $1,649 
The table below presents our income available to nonredeemable noncontrolling interests by segment:
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2025202420252024
Hospital Operations$12 $12 $24 $21 
Ambulatory Care93 85 176 158 
Total net income available to nonredeemable noncontrolling interests
$105 $97 $200 $179 
Share Repurchase Program Activity
In October 2022, our board of directors authorized the repurchase of up to $1.000 billion of our common stock through a share repurchase program (the “2022 share repurchase program”). This program allowed for share repurchases to be made in open‑market or privately negotiated transactions, at management’s discretion subject to market conditions and other factors, and in a manner consistent with applicable securities laws and regulations. The program did not require us to acquire any particular amount of common stock and could be suspended for periods or discontinued at any time. In July 2024, our board authorized a new share repurchase program (the “2024 share repurchase program”) of up to $1.500 billion of our common stock with no expiration date, under terms substantially similar to the 2022 share repurchase program. We did not make any additional repurchases under the 2022 share repurchase program following the approval of the 2024 share repurchase program.

The table below presents repurchase activity under both the 2022 and 2024 share repurchase programs:
PeriodTotal Number of Shares PurchasedAverage Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Program
Maximum Dollar Value of Shares That May Yet Be Purchased Under the Program(1)
 (In Thousands)(In Thousands)(In Millions)
Six Months Ended June 30, 2025:
January 1 through January 31, 2025—$— —$1,376 
February 1 through February 28, 20251,800$134.98 1,800$1,133 
March 1 through March 31, 2025829$126.67 829$1,028 
April 1 through April 30, 2025—$— —$1,028 
May 1 through May 31, 20252,456$157.57 2,456$641 
June 1 through June 30, 20252,145$167.83 2,145$281 
January 1 through June 30, 20257,230$151.45 7,230
Six Months Ended June 30, 2024:
January 1 through January 31, 2024—$— —$550 
February 1 through February 29, 2024—$— —$550 
March 1 through March 31, 20242,811$98.86 2,811$272 
April 1 through April 30, 2024—$— —$272 
May 1 through May 31, 2024—$— —$272 
June 1 through June 30, 20241,990$135.85 1,990$2 
January 1 through June 30, 20244,801$114.19 4,801
(1)
In July 2025, our board of directors authorized a $1.500 billion increase to the 2024 share repurchase program. With this new authorization, $1.781 billion was available for repurchases of our common stock as of July 22, 2025.